NEUP (STOCKS)
Neuphoria Therapeutics Inc. Common Stock
$3.830000
+0.020000 (+0.52%)
Prev close: $3.810000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Spyridon Papapetropoulos
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $20.81M
- Employees
- 8
- P/E (TTM)
- -0.16
- P/B (TTM)
- 0.70
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q3)
|
$-0.09 | $-0.99 | +0.8994 | +90.90% |
|
Dec 2025 (Q2)
|
$-0.77 | $-1.49 | +0.7226 | +48.41% |
|
Sep 2025 (Q1)
|
$-4.41 | $-1.35 | -3.0568 | -225.89% |
|
Jun 2025 (Q4)
|
$-5.79 | $-2.12 | -3.6718 | -173.35% |